A Fortune 500 biotech leader is focused on delivering the next generation of therapeutics that will address market demand and increase production to alleviate pressures. To do this, they decided to build a new manufacturing campus in the United States by transforming an existing facility into a 168-square-foot biomanufacturing hub for chromatography resins. With a budget of $850 million and a 2026 target date, they needed to make sure that operations would run seamlessly and efficiently.
We executed a full engineering, procurement, and construction management project (EPCM) for the client’s updated life sciences infrastructure plans, using one of their sites as a basis for project operations.
Arcadis assembled a project team from its US and Ireland offices to deliver our project expertise in a collaborative manner. We completed conceptual and basic design for the site while also offering detailed design for the facility, electrical, mechanical, HVAC, cleanrooms, and other processes, such as support for utilities, offices, laboratories, and other amenities. We also provided direct input to the design basis for sustainability, wastewater treatment, environmental health and safety, commissioning, and qualification.
Our strategic efforts are ensuring that the project is on track with its schedule and budget as it progresses toward its 2026 completion target.
Through the application of lean methods in this initiative’s life sciences facility management, Arcadis was able to increase project efficiency and optimize the utilization of over 300 pieces of equipment, including mechanical, electrical, and process. Due to these outcomes, we have become a trusted partner to the client, resulting in additional projects and efforts at their other sites.
Create a better future with us
